Literature DB >> 23147253

Exome sequencing in tracking clonal evolution in multiple myeloma following therapy.

N Weston-Bell, J Gibson, M John, S Ennis, S Pfeifer, T Cezard, H Ludwig, A Collins, N Zojer, S S Sahota.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23147253     DOI： 10.1038/leu.2012.287

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  11 in total

Review 1.  DNA repair pathways in human multiple myeloma: role in oncogenesis and potential targets for treatment.

Authors:  Claire Gourzones-Dmitriev; Alboukadel Kassambara; Surinder Sahota; Thierry Rème; Jérôme Moreaux; Pascal Bourquard; Dirk Hose; Philippe Pasero; Angelos Constantinou; Bernard Klein
Journal:  Cell Cycle       Date:  2013-08-09       Impact factor: 4.534

Review 2.  Molecular basis of clonal evolution in multiple myeloma.

Authors:  Yusuke Furukawa; Jiro Kikuchi
Journal:  Int J Hematol       Date:  2020-02-06       Impact factor: 2.490

Review 3.  Single-cell profiling of tumour evolution in multiple myeloma - opportunities for precision medicine.

Authors:  Ankit K Dutta; Jean-Baptiste Alberge; Romanos Sklavenitis-Pistofidis; Elizabeth D Lightbody; Gad Getz; Irene M Ghobrial
Journal:  Nat Rev Clin Oncol       Date:  2022-01-11       Impact factor: 65.011

Review 4.  Clonal evolution in hematological malignancies and therapeutic implications.

Authors:  D A Landau; S L Carter; G Getz; C J Wu
Journal:  Leukemia       Date:  2013-08-27       Impact factor: 11.528

5.  Massive parallel IGHV gene sequencing reveals a germinal center pathway in origins of human multiple myeloma.

Authors:  Graeme Cowan; Nicola J Weston-Bell; Dean Bryant; Anja Seckinger; Dirk Hose; Niklas Zojer; Surinder S Sahota
Journal:  Oncotarget       Date:  2015-05-30

6.  RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma.

Authors:  E Viziteu; B Klein; J Basbous; Y-L Lin; C Hirtz; C Gourzones; L Tiers; A Bruyer; L Vincent; C Grandmougin; A Seckinger; H Goldschmidt; A Constantinou; P Pasero; D Hose; J Moreaux
Journal:  Leukemia       Date:  2017-02-10       Impact factor: 11.528

7.  Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single-cell level by QM-FISH.

Authors:  Yuting Yan; Xiaoqi Qin; Jiahui Liu; Huishou Fan; Wenqiang Yan; Lanting Liu; Chenxing Du; Zhen Yu; Yan Xu; Mu Hao; Shuhui Deng; Weiwei Sui; Rui Lyu; Wei Liu; Qi Wang; Dehui Zou; Linping Hu; Jianxiang Wang; Yu-Tzu Tai; Kenneth C Anderson; Lei Zhang; Tao Cheng; Anders Zetterberg; Nikhil C Munshi; Lugui Qiu; Gang An
Journal:  Blood Adv       Date:  2022-01-25

8.  Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms.

Authors:  Brian A Walker; Christopher P Wardell; Lorenzo Melchor; Annamaria Brioli; David C Johnson; Martin F Kaiser; Fabio Mirabella; Lucia Lopez-Corral; Sean Humphray; Lisa Murray; Mark Ross; David Bentley; Norma C Gutiérrez; Ramón Garcia-Sanz; Jesus San Miguel; Faith E Davies; David Gonzalez; Gareth J Morgan
Journal:  Leukemia       Date:  2013-07-02       Impact factor: 11.528

9.  Serial exome analysis of disease progression in premalignant gammopathies.

Authors:  S Zhao; M Choi; C Heuck; S Mane; B Barlogie; R P Lifton; M V Dhodapkar
Journal:  Leukemia       Date:  2014-02-05       Impact factor: 12.883

10.  Detection of recurrent cytogenetic aberrations in multiple myeloma: a comparison between MLPA and iFISH.

Authors:  Meirong Zang; Dehui Zou; Zhen Yu; Fei Li; Shuhua Yi; Xiaofei Ai; Xiaoqi Qin; Xiaoyan Feng; Wen Zhou; Yan Xu; Zengjun Li; Mu Hao; Weiwei Sui; Shuhui Deng; Chirag Acharya; Yaozhong Zhao; Kun Ru; Lugui Qiu; Gang An
Journal:  Oncotarget       Date:  2015-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.